Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainRibosomal_L39_CS

RPL39L RPL39

1.58e-062242IPR020083
DomainRibosomal_L39e_dom

RPL39L RPL39

1.58e-062242IPR023626
DomainRibosomal_L39

RPL39L RPL39

1.58e-062242IPR000077
DomainRibosomal_L39

RPL39L RPL39

1.58e-062242PF00832
Domain-

RPL39L RPL39

1.58e-0622421.10.1620.10
DomainRIBOSOMAL_L39E

RPL39L RPL39

1.58e-062242PS00051
DomainHomeodomain-like

VRTN UBTF CUX2

8.54e-03332243IPR009057
Pubmed

Deletion of ribosomal paralogs Rpl39 and Rpl39l compromises cell proliferation via protein synthesis and mitochondrial activity.

RPL39L RPL39

4.56e-07224234428590
Pubmed

E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinoma.

WEE1 E2F8

1.37e-06324237863324
Pubmed

Maternal DCAF13 Regulates Chromatin Tightness to Contribute to Embryonic Development.

UBTF RPL39

2.50e-051124231000741
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

UBTF ZBTB24 CUX2 MKRN1 ZNF445

1.97e-0480824520412781
Pubmed

Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells during development.

SETDB1 CUX2

2.68e-043524222991445
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

ZBTB24 UNC80 CUX2

4.89e-0422524312168954
Pubmed

The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

DNHD1 RMDN3 DEFB132 ITLN2 FGF22

4.90e-0498524512975309
Pubmed

The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation.

MKRN1 NCBP3

6.63e-045524231640799
InteractionRPL39L interactions

RPL39L RPL39

1.36e-055242int:RPL39L
CytobandEnsembl 112 genes in cytogenetic band chr2q34

KANSL1L UNC80

2.56e-0445242chr2q34
CytobandEnsembl 112 genes in cytogenetic band chr11p15

DNHD1 WEE1 E2F8

3.08e-03564243chr11p15
GeneFamilyL ribosomal proteins

RPL39L RPL39

5.97e-0451132729
GeneFamilyRing finger proteins

MKRN1 RNF175

1.61e-0227513258
ToppCellBAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

RPL39L WEE1 E2F8 HJURP

3.47e-061962446d80e23f6a1725a3f5ea7263233c55c2ea56f977
ToppCellBAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RPL39L WEE1 E2F8 HJURP

3.47e-061962444f649e3bfd21f21682678828673843a7d51c4ff2
ToppCellBAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RPL39L WEE1 E2F8 HJURP

3.47e-06196244bf1d3fae8c01bb3d17c2dafad92b94937c663acd
ToppCellBAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

RPL39L WEE1 E2F8 HJURP

3.47e-06196244799c290fb3dfacb666dd0dc3c43ec8a86b697ec7
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

RPL39L WEE1 E2F8 HJURP

3.47e-061962449591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCellBAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RPL39L WEE1 E2F8 HJURP

3.47e-061962440c003a767c3b58605099dab64b9df0d8e5d8bc4b
ToppCellHealthy-T/NK_proliferative|Healthy / disease group, cell group and cell class

RPL39L WEE1 E2F8 HJURP

3.47e-0619624491e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCellBAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

RPL39L WEE1 E2F8 HJURP

3.47e-061962443dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496
ToppCellHealthy-T/NK_proliferative|World / disease group, cell group and cell class

RPL39L WEE1 E2F8 HJURP

3.54e-06197244e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCellHealthy_Control-Lymphoid-T-Proliferating_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass

RPL39L WEE1 E2F8 HJURP

3.54e-061972443ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

RPL39L WEE1 E2F8 HJURP

3.68e-0619924488d130e2451e61afb710edf552e6b346b9fcfb2b
ToppCellMNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id

RPL39L WEE1 E2F8 HJURP

3.68e-061992445952980d0ece5d73f3e9f340c56a38b34d2f2309
ToppCellLAM-Myeloid-pMacrophage|Myeloid / Condition, Lineage and Cell class

RPL39L WEE1 E2F8 HJURP

3.76e-062002440078d56337d44074326e8ccd1d412d098d86eeab
ToppCell(3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

RPL39L WEE1 E2F8 HJURP

3.76e-06200244d94fe9bd6ee7c1fed14666f24de41bda014e299b
ToppCellSepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class

RPL39L WEE1 E2F8 HJURP

3.76e-0620024499acc1ea01288efdd5b166aa20d66735f2bbe543
ToppCellASK454-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

UBTF NCBP3

1.79e-0512242f8ea75314b9fa2bdc57564cad9640893a47f0340
ToppCell368C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

RNF175 HJURP FGF22

5.93e-051422435ef69032ed7dc5f2244b84e8c6662290bf59a34b
ToppCellHealthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass

RPL39L DNHD1 ZBTB24

8.93e-051632432913ccdd4613472cd82077d4993e1d9f8b223398
ToppCellHealthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

RPL39L DNHD1 ZBTB24

8.93e-05163243b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCellLPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WEE1 E2F8 HJURP

8.93e-051632435285318c52aa31c9b22dc2ffff078e32e408604d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

WEE1 E2F8 HJURP

9.94e-05169243b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WEE1 E2F8 HJURP

9.94e-05169243e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

RPL39L E2F8 HJURP

1.03e-041712434ede6e916e593f208f2f8ccf82ef2335e061fc86
ToppCell10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue

E2F8 C1orf167 HJURP

1.07e-04173243d815832f89f70662706620e3b03ebb1dabec0034
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WEE1 E2F8 HJURP

1.08e-04174243b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WEE1 E2F8 HJURP

1.08e-0417424394575a605c725de83f66a6cf7df9d7bb360ffc56
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

WEE1 E2F8 HJURP

1.08e-0417424340c81ab36d7931e271e20d7d56fed32463c75f41
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells)

RPL39L RNF175 HJURP

1.08e-04174243a75ba49ccea6bd3d78ada1092b46deb5202c58a5
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

WEE1 E2F8 HJURP

1.10e-04175243553e68e8b439a2293efb969e1e2aa017ceb80daf
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

WEE1 E2F8 HJURP

1.10e-0417524316d4e97271df1db9a0d167fc82a90d84d20dd1f2
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

WEE1 E2F8 HJURP

1.10e-04175243289d2aa7164bc02b1876b99f2fb67baa8e030c4e
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

RPL39L E2F8 HJURP

1.10e-041752436b4e841bde6cfa4956e1a0231672cea20f11210c
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells)

RPL39L E2F8 HJURP

1.14e-04177243ba701d3c90722d8bff70d0fa651899305cdad257
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

RPL39L E2F8 HJURP

1.18e-04179243ac987c9425a1b4106d1b8779a2c5461383eae2ae
ToppCellLPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WEE1 E2F8 HJURP

1.20e-04180243334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCellCV-Healthy-2|CV / Virus stimulation, Condition and Cluster

E2F8 RPL39 HJURP

1.20e-04180243e182e5c495dd82d4fcbf1a920086c70b064801f3
ToppCellcontrol-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

RPL39L RPL39 HJURP

1.20e-04180243535535a67b3f3320bad2f98b1bc98a7b0ee77840
ToppCellHealthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

WEE1 E2F8 HJURP

1.22e-04181243ac1ee313910c05b1b3cb497bae14565464919c21
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue

RPL39L E2F8 HJURP

1.26e-04183243a48a6313f2f144586951cece97ec31f6d72361df
ToppCellControl-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class （2021.01.30）

WEE1 E2F8 HJURP

1.26e-04183243e740f05536d1e4b2512811771928eb65f6696409
ToppCellBac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type

RPL39L E2F8 HJURP

1.28e-04184243848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b
ToppCellCOVID-cycling-|COVID / Condition, Cell_class and T cell subcluster

RPL39L E2F8 HJURP

1.30e-04185243eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f
ToppCellCOVID-cycling|COVID / Condition, Cell_class and T cell subcluster

RPL39L E2F8 HJURP

1.30e-041852435112f966735fa48f0606adcfd5c0212ad5d3d77a
ToppCellDividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

RPL39L E2F8 HJURP

1.32e-041862430067eb78d4c7e32b9563550d9fcaf13445ee6a48
ToppCellDividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id

RPL39L E2F8 HJURP

1.38e-04189243d4e88a3e50499d683e3db38aee04490146fe30bb
ToppCellControl-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WEE1 E2F8 HJURP

1.38e-041892431e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCellInt-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type

WEE1 E2F8 HJURP

1.41e-04190243005967c540418b85311308072a07c684f4296aef
ToppCellnormal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass

RPL39L E2F8 HJURP

1.41e-04190243165c61443ff0c8efbdad3b052bb00f46d81c5203
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RPL39L PIGR E2F8

1.41e-041902430adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RPL39L PIGR E2F8

1.41e-0419024305455775845f4ded5c27e7b83242078d23162aaf
ToppCellDividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id

RPL39L E2F8 HJURP

1.43e-041912433e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

RPL39L E2F8 HJURP

1.47e-04193243cf680afddc08b6481f1b3eee9c57acfaebeac6f0
ToppCellControl-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class

WEE1 E2F8 HJURP

1.47e-0419324333d409d6ed1c606337248587ad997ac5f67f081d
ToppCell(1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

RPL39L E2F8 HJURP

1.49e-041942438f313071933451780309d2174ed27d8cdc734343
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells)

RPL39L E2F8 HJURP

1.49e-04194243a12b64945e10f00aa983678a02586c59badc1570
ToppCellDividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

RPL39L E2F8 HJURP

1.52e-0419524379ee423df85aa1631b7bdea74eacaf826dfc4a2c
ToppCell(1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

RPL39L E2F8 HJURP

1.52e-04195243cf00a0b4f341f0487d5b37810abe2952fdd3f6f2
ToppCellHealthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class

RPL39L E2F8 HJURP

1.52e-04195243957458fdc39723f4a31bd7fd3ce32891aa3fd462
ToppCellDividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

RPL39L E2F8 HJURP

1.52e-0419524319829760dfcc0edafd2a2bd80f424a45d039af1f
ToppCellmild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

WEE1 E2F8 HJURP

1.52e-041952439a8cc9097a349fd0a53ccf2723ee8bb1418d6aca
ToppCellInfluenza_Severe-T/NK_proliferative|World / Disease group and Cell class

RPL39L E2F8 HJURP

1.52e-041952436f079c2d7d08110a5e1822ea861b8037eb3f62c9
ToppCell(4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

RPL39L E2F8 HJURP

1.52e-0419524354d2acaff6be6b5604591bdbd7d769ac3e74f223
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells)

E2F8 RNF175 HJURP

1.52e-0419524347a01b8a92eebeb34ac7f70bf1ab4613a326e24f
ToppCellmetastatic_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass

PIGR RPL39 HJURP

1.54e-04196243c17e105e47446a48aa06e1a3810828e20aa56ea9
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

RPL39L E2F8 HJURP

1.54e-0419624334bd155e6d848eb53d613997c0e244535de30ba3
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

RPL39L E2F8 HJURP

1.54e-04196243f70a2b227716a0df3c1aa6a414b822e63f209a43
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

WEE1 E2F8 HJURP

1.54e-041962435905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCellFLU-Healthy-2|FLU / Virus stimulation, Condition and Cluster

RPL39L WEE1 HJURP

1.54e-041962430f2240a64a1cdd3147f2330f51c871cd0df8c055
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

RPL39L E2F8 HJURP

1.56e-04197243434a5686a103bb766e0d80038413f0e12ea3981a
ToppCell(3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

RPL39L E2F8 HJURP

1.56e-04197243048bc4f8fd5d4f394e2384700640f72042336597
ToppCellsevere_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2)

RPL39L E2F8 HJURP

1.56e-04197243189d97a6c2ff8803db8cc05e205c9d88dac3911f
ToppCellMild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass

RPL39L E2F8 HJURP

1.56e-04197243794517c70089da109f4c6489fe406c0ba6882b76
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

RPL39L E2F8 HJURP

1.56e-041972436bddfa199ca812d9e518eaa02c3d4fb67e9f5b16
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

RPL39L E2F8 HJURP

1.56e-04197243c0a71a9452febda433bc544e4ac0a79c43dcf13e
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RPL39L E2F8 HJURP

1.56e-04197243f34b1e34f1f0694564031077172c890b233ce8b7
ToppCellControl-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class （2021.01.30）

WEE1 E2F8 HJURP

1.56e-04197243ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e
ToppCelldistal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RPL39L E2F8 HJURP

1.56e-0419724304b10879e48c101d1de449db0bc6b6484090b965
ToppCellHealthy/Control-T/NK_proliferative|World / Disease group and Cell class

RPL39L E2F8 HJURP

1.56e-041972434a4d3083938783d6f5b87da02f10e501917da0b4
ToppCellmild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

WEE1 E2F8 HJURP

1.56e-04197243bd9d57e0c873f6526dca322f4dad8e6bd692586c
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RPL39L E2F8 HJURP

1.56e-04197243d7a9296092153cf66426911fecd810f0c1ef978e
ToppCellBAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RPL39L E2F8 HJURP

1.56e-04197243dcff23240bb7cb652d7426b29355aa74442ef6fc
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

RPL39L E2F8 HJURP

1.56e-0419724347be19f595135da248469b2e21b8d88f561827b2
ToppCellHealthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2)

RPL39L E2F8 HJURP

1.56e-04197243b6bbf87e5823fa66b4cad6a7be4f777356887b59
ToppCellmyeloid-CD34+_Monoblast|myeloid / Lineage and Cell class

RPL39L WEE1 RPL39

1.59e-04198243e26b98a8380e693110a97d8e5a353998f8d67c6d
ToppCelldistal-Hematologic-Proliferating_NK/T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RPL39L E2F8 HJURP

1.59e-041982435c14b152912429f099dfcb6bcb1aec80314a3284
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

RPL39L E2F8 HJURP

1.59e-041982436a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb
ToppCellnormal_Lung-T/NK_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass

RPL39L E2F8 HJURP

1.59e-04198243c65cdb54409087014125a76627e5efb5fe8dabc9
ToppCelldistal-3-Hematologic-Proliferating_NK/T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RPL39L E2F8 HJURP

1.59e-04198243aa23119d73554733981df474648e59918d04edfc
ToppCelldistal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RPL39L E2F8 HJURP

1.59e-04198243df3f5559ecd1f3cd1fd60e39dbad8741309e83a3
ToppCellsevere_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2)

RPL39L E2F8 HJURP

1.59e-04198243ed86b0247006befe55400c287d334d2202b470bd
ToppCellmetastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass

RPL39L E2F8 HJURP

1.59e-0419824321c4762ca8591804cf77a23b64470e60d25c5357
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

WEE1 E2F8 HJURP

1.59e-04198243f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

WEE1 E2F8 HJURP

1.59e-041982437225a6194c52b01c581e58d3cda107c4af96dc4f
ToppCelldistal-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

RPL39L E2F8 HJURP

1.59e-04198243a5fd710df5669c95fc5b5ef6e5cfafe6687c7b72
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

RPL39L E2F8 HJURP

1.59e-041982436981cd5b1585c8ae6febdf0c4fb83067127f106c
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

RPL39L E2F8 HJURP

1.59e-0419824348d39018c56ea8ba972c72af8ece10cbeb48fbc8
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

RPL39L E2F8 HJURP

1.59e-04198243281fc2536cdc4c717b30de156e563c0e4baba99d
ToppCell(1)_T_cell_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

RPL39L E2F8 HJURP

1.59e-04198243dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a
ToppCellsevere_influenza-T/NK_proliferative|severe_influenza / disease group, cell group and cell class (v2)

RPL39L E2F8 HJURP

1.61e-04199243638b1491c47f2884daf1c1d38a779ad8e0f59c52
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

RPL39L E2F8 HJURP

1.61e-041992433d876f172487425b37b2f658dae59e0f293ee76e
Drugstaurosporine; Down 200; 1uM; MCF7; HG-U133A

WEE1 ZBTB24 E2F8 HJURP

3.63e-05181244312_DN
DrugGW8510; Down 200; 10uM; MCF7; HT_HG-U133A

WEE1 SETDB1 E2F8 HJURP

3.78e-051832447062_DN
DrugMitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A

WEE1 ZBTB24 E2F8 HJURP

3.78e-051832443232_DN
DrugDoxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A

WEE1 ZBTB24 E2F8 HJURP

3.87e-051842445671_DN
DrugH-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A

WEE1 ZBTB24 E2F8 HJURP

4.29e-051892445936_DN
DrugTocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A

KANSL1L SETDB1 UBTF HJURP

4.75e-051942444838_UP
Diseasesystolic blood pressure, alcohol drinking

CUX2 C1orf167

4.07e-03128222EFO_0004329, EFO_0006335
Diseaseglycine measurement

KANSL1L UNC80

4.65e-03137222EFO_0009767
Diseasecoffee consumption measurement

SETDB1 CUX2

8.06e-03182222EFO_0006781

Protein segments in the cluster

PeptideGeneStartEntry
GTARWYQHTRQRRIF

C1orf167

896

Q5SNV9
HRRRGSFSSENYWRK

ALKBH5

356

Q6P6C2
LYGTRLQAHRGRWSQ

DNHD1

4276

Q96M86
TVINWFHNYRSRMRR

CUX2

1211

O14529
IGNHWQSRRRNTQRK

DEFB132

71

Q7Z7B7
QNWNSRRRHRYKSRM

HJURP

291

Q8NCD3
QSKWHRRNSRAYSKN

KANSL1L

846

A0AUZ9
SNSWKRRYHSRRIQR

NCBP3

296

Q53F19
ENGHNTYASQRWRRR

FGF22

121

Q9HCT0
SRLAKNRYTWHGRHN

E2F8

171

A0AVK6
QHWRNSALLRYRTNT

ITLN2

171

Q8WWU7
GTSSRYRAQRRNHFW

MKRN1

406

Q9UHC7
YSQRWKRTQRHGRSQ

RMDN3

31

Q96TC7
RYNSKRRHWRRTKLG

RPL39L

36

Q96EH5
TGNKIRYNSKRRHWR

RPL39

31

P62891
RYNSKRRHWRRTKLG

RPL39

36

P62891
VWRSYATRRQTRGQK

SETDB1

921

Q15047
HSSGQCRRRKRTYWN

WEE1

246

P30291
HRNYSFRRGSVWSVR

UNC80

1801

Q8N2C7
VQWRQRHGRSYNLVT

RNF175

71

Q8N4F7
SVNRHTRKYWCRQGA

PIGR

46

P01833
GQASQSRYSKRRIWR

ZBTB24

246

O43167
GKAFRWSSNLYRHQR

ZNF445

796

P59923
GSRWQRISQSQKEHY

UBTF

601

P17480
FYRWRRQSQEHRQKV

VRTN

296

Q9H8Y1